The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor (R) Descriptors for Non-Small Cell Lung Cancer.
To validate the prognostic relevance in NSCLC of potential residual tumor (R) descriptors, including the proposed International Association for the Study of Lung Cancer definition for uncertain resection -R(un). 14,712 patients undergoing resection with full R status and survival were analyzed. The following were also evaluated: <3 N2 stations explored; lobe-specific nodal dissection (LSND); extra-capsular extension (ECE); highest lymph node station status; carcinoma in situ at bronchial resection margin (BRMcis); pleural lavage cytology (PLC). Revised categories of R0, R(un), R1 and R2 were tested for survival impact. 14,293 cases were R0, 263 R1 and 156 R2 (median survival: not reached, 33, 29 months, respectively). R status correlated with T and N categories. 9,290 (63%) cases had ≥3 N2 stations explored and 6,641 (45%) had LSND, correlated with increasing pN2. ECE was present in 62 (17%) of 364 cases with available data. The highest station was positive in 942 (6.4%). PLC was positive in 59 (3.5%) of 1,705 cases: 13 had BRMcis. After reassignment, due to inadequate nodal staging in 56%, 6,070 cases were R0, 8,185 R(un), 301 R1 and 156 R2. In node positive cases, median survival was 70, 50, 30 months for R0, R(un), (p<0.0001) and R1 (p<0.001), respectively, with no significant difference between R0 and R(un) in pN0 cases. R descriptors have prognostic relevance with R(un) survival stratifying between R0 and R1. Therefore, a detailed evaluation of R factor is of particular importance in the design and analyses of clinical trials of adjuvant therapies.